Tools & accessories · Industrials · Fiscal year ends Dec 31
Simpson Manufacturing reported revenue of $2.3B in the fiscal year ended Dec 2025, up 4.5% from the year before. Operating income was $458M, an operating margin of 19.6%, and net income was $345M. Operating cash flow of $459M less capital expenditure of $161M left free cash flow of $298M. It held more cash than debt (net cash $69M).
Ranks among the 3 tools & accessories companies we cover (1st = best; for debt, the least indebted). Green = top third, red = bottom third.
Last 5 fiscal years
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1,573 | 2,116 | 2,214 | 2,232 | 2,333 |
| Cost of revenue | 818 | 1,175 | 1,172 | 1,208 | 1,263 |
| Gross profit | 755 | 941 | 1,042 | 1,024 | 1,070 |
| Research & development | 12.3 | 15.7 | 24.8 | 20.7 | 11.5 |
| Selling, general & admin | 328 | 398 | 476 | 507 | 544 |
| Operating income | 368 | 459 | 475 | 430 | 458 |
| Interest expense | 0.9 | 8.0 | 4.5 | 2.3 | −9.0 |
| Pre-tax income | 359 | 448 | 477 | 434 | 462 |
| Income tax | 92.1 | 114 | 123 | 112 | 117 |
| Net income | 266 | 334 | 354 | 322 | 345 |
| Diluted EPS | 6.12 | 7.76 | 8.26 | 7.60 | 8.24 |
| Diluted shares | 43.5 | – | 42.8 | 42.4 | 41.9 |
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Cash & equivalents | 301 | 301 | 430 | 239 | 384 |
| Receivables | 231 | 269 | 284 | 284 | 303 |
| Inventory | 444 | 557 | 552 | 593 | 594 |
| Current assets | 999 | 1,179 | 1,312 | 1,176 | 1,353 |
| Net PP&E | 260 | 362 | 419 | 532 | 628 |
| Goodwill | 134 | 496 | 503 | 512 | 559 |
| Total assets | 1,484 | 2,504 | 2,705 | 2,736 | 3,074 |
| Payables | 57.2 | 97.8 | 108 | 101 | 91.5 |
| Current liabilities | 245 | 349 | 361 | 366 | 382 |
| Short-term debt | 0.0 | 22.5 | 22.5 | 22.5 | 15.0 |
| Long-term debt | – | 433 | 411 | 388 | 300 |
| Total liabilities | 300 | 1,091 | 1,025 | 923 | 1,038 |
| Shareholders' equity | 1,184 | 1,413 | 1,680 | 1,805 | 2,030 |
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating cash flow | 151 | 400 | 427 | 338 | 459 |
| Capital expenditure | 43.7 | 62.4 | 88.8 | 180 | 161 |
| Free cash flow | 108 | 337 | 338 | 158 | 298 |
| Depreciation & amortisation | 42.5 | 60.9 | 74.7 | 85.4 | 90.0 |
| Stock-based compensation | 17.7 | 15.0 | 23.9 | 19.0 | 23.0 |
| Acquisitions | 0.2 | 811 | 23.4 | 79.2 | 2.1 |
| Share buybacks | 24.1 | 78.6 | 50.0 | 100 | 120 |
| Dividends paid | 41.6 | 43.9 | 45.2 | 46.5 | 47.6 |
| Dividend per share | 0.98 | 1.03 | 1.07 | 1.11 | 1.15 |
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue growth (YoY) | – | 34.5% | 4.6% | 0.8% | 4.5% |
| Operating income growth (YoY) | – | 24.8% | 3.5% | −9.5% | 6.5% |
| EPS growth (YoY) | – | 26.8% | 6.4% | −8.0% | 8.4% |
| Gross margin | 48.0% | 44.5% | 47.1% | 45.9% | 45.9% |
| Operating margin | 23.4% | 21.7% | 21.5% | 19.3% | 19.6% |
| Net margin | 16.9% | 15.8% | 16.0% | 14.4% | 14.8% |
| Return on equityBlank when equity is negative | 22.5% | 23.6% | 21.1% | 17.8% | 17.0% |
| ROCEEBIT ÷ (assets − current liabilities) | 29.7% | 21.3% | 20.3% | 18.1% | 17.0% |
| Free cash flow margin | 6.8% | 15.9% | 15.3% | 7.1% | 12.8% |
| Cash conversion (CFO ÷ net income) | 0.57x | 1.20x | 1.21x | 1.05x | 1.33x |
| Receivable days | 54 | 46 | 47 | 47 | 47 |
| Inventory days | 198 | 173 | 172 | 179 | 172 |
| Payable days | 26 | 30 | 33 | 31 | 26 |
| Interest cover | 433x | 57.2x | 106x | 189x | −50.8x |
| Debt ÷ equity | – | 0.32x | 0.26x | 0.23x | 0.16x |
| Net debtDebt − cash & equivalents; excludes investments; negative = net cash | – | 155 | 3.3 | 171 | −69.1 |
| Current ratio | 4.08x | 3.38x | 3.63x | 3.21x | 3.54x |
Standardised figures from the company's XBRL filings with the SEC (10-K, 10-Q). Line items follow US GAAP tags, so a company's own statement layout may differ and some lines show “–” where the company does not report that item. Ratios are calculated from these figures. For education only; not investment advice or a recommendation.